Ori Lev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ori Lev has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Arnon Keren
University of Haifa
2 shared publications - Abdul Wadud Khan
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
1 shared publication - Adi Diab
The University of Texas MD Anderson Cancer Center, Houston, TX
1 shared publication - Alexander Joseph Lazar
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
1 shared publication - Alexandria P. Cogdill
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
1 shared publication - Amit Avigur-Eshel
Sapir College
1 shared publication
Latest Publications
- 3 July 2025
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 25 (7) , 141-143
Two Kinds of Ignorance and Their Implications for Informed Consent
- 3 July 2025
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 25 (7) , 141-143
Two Kinds of Ignorance and Their Implications for Informed Consent
- Open Access
- 31 July 2024
- Published by SAGE Publications in Research Ethics
- Vol. 21 (2) , 267-285
Addressing the risks of dual use research: who is responsible?
This article addresses the question of how the responsibilities for addressing the risks of dual use research ought to be divided. We begin by presenting the maximalist claim that proposes that since scientists are well placed to judge the potential for misuse of their studies, they alone are responsible for addressing these risks. Before assessing this position, we consider a claim that rejects the maximalist position, namely that scientists need not consider the possibility that their studies might be misused because the goods of science are so important, they should not spend time on anything but generating valuable knowledge. This claim, we argue, fails, as these goods do not always outweigh the risks of misuse. Given this conclusion we turn to assess two versions of the maximalist claim. The first suggests that when a possibility of misuse arises, scientists ought to adopt the precautionary principle (PP) to discharge their moral responsibilities. We argue that PP is problematic as it does not give much guidance on what scientists should do. An alternative to meeting scientists’ moral responsibilities is through applying a risk-benefit analysis; however, due to epistemic biases and limitations, scientists are prone to make mistakes in their analysis. We thus suggest an alternative approach, in which responsibilities are divided between scientists and agents that can conduct an analysis that is more likely to generate unbiased and comprehensive conclusions on how the risks of dual use research, should be addressed.
- 31 July 2024
- Published by SAGE Publications in Research Ethics
- Vol. 21 (2) , 267-285
Open AccessAddressing the risks of dual use research: who is responsible?
This article addresses the question of how the responsibilities for addressing the risks of dual use research ought to be divided. We begin by presenting the maximalist claim that proposes that since scientists are well placed to judge the potential for misuse of their studies, they alone are responsible for addressing these risks. Before assessing this position, we consider a claim that rejects the maximalist position, namely that scientists need not consider the possibility that their studies might be misused because the goods of science are so important, they should not spend time on anything but generating valuable knowledge. This claim, we argue, fails, as these goods do not always outweigh the risks of misuse. Given this conclusion we turn to assess two versions of the maximalist claim. The first suggests that when a possibility of misuse arises, scientists ought to adopt the precautionary principle (PP) to discharge their moral responsibilities. We argue that PP is problematic as it does not give much guidance on what scientists should do. An alternative to meeting scientists’ moral responsibilities is through applying a risk-benefit analysis; however, due to epistemic biases and limitations, scientists are prone to make mistakes in their analysis. We thus suggest an alternative approach, in which responsibilities are divided between scientists and agents that can conduct an analysis that is more likely to generate unbiased and comprehensive conclusions on how the risks of dual use research, should be addressed.
- 26 February 2022
- Published by Springer Nature in Ethical Theory and Moral Practice
- Vol. 25 (2) , 351-368
Informed Consent, Error and Suspending Ignorance: Providing Knowledge or Preventing Error?
- 26 February 2022
- Published by Springer Nature in Ethical Theory and Moral Practice
- Vol. 25 (2) , 351-368
Informed Consent, Error and Suspending Ignorance: Providing Knowledge or Preventing Error?
- Top Cited Papers
- 23 December 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 374 (6575) , 1632-1640
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Another benefit of dietary fiber: The gut microbiome can modulate the immune system and influence the therapeutic response of cancer patients, yet the mechanisms underlying the effects of microbiota are presently unclear. Spencer et al . add to our understanding of how dietary habits affect microbiota and clinical outcomes to immunotherapy. In an observational study, the researchers found that melanoma patients reporting high fiber (prebiotic) consumption had a better response to checkpoint inhibitor immunotherapy compared with those patients reporting a low-fiber diet. The most marked benefit was observed for those patients reporting a combination of high fiber consumption and no use of over-the-counter probiotic supplements. These findings provide early insights as to how diet-related factors may influence the immune response. —PNK
- 23 December 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 374 (6575) , 1632-1640
Top Cited PapersDietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Another benefit of dietary fiber: The gut microbiome can modulate the immune system and influence the therapeutic response of cancer patients, yet the mechanisms underlying the effects of microbiota are presently unclear. Spencer et al . add to our understanding of how dietary habits affect microbiota and clinical outcomes to immunotherapy. In an observational study, the researchers found that melanoma patients reporting high fiber (prebiotic) consumption had a better response to checkpoint inhibitor immunotherapy compared with those patients reporting a low-fiber diet. The most marked benefit was observed for those patients reporting a combination of high fiber consumption and no use of over-the-counter probiotic supplements. These findings provide early insights as to how diet-related factors may influence the immune response. —PNK
- Open Access
- 4 August 2014
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 2, 110
Biosecurity Policy in the US: A Critical Assessment
Biosecurity Policy in the US: A Critical Assessment
- 4 August 2014
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 2, 110
Open AccessBiosecurity Policy in the US: A Critical Assessment
Biosecurity Policy in the US: A Critical Assessment